Grifols GRFS
NASDAQ GRFS
$7.31 +0.01 (+0.14%)
At close: Sep 30, 2026 · 4:00 PM EDT

Grifols (GRFS) Current Leases (2013 - 2016)

Updated

Grifols (GRFS) recorded Current Leases of $6.9 million in the quarter ended Mar 31, 2016, up 7.6% from the prior quarter.

Analysis

Grifols (GRFS) Current Leases (2013 - 2016) Analysis & Trends

As of Dec 31, 2015, Grifols reported Current Leases of $6.5 million.

  • Across earlier years, Current Leases came in at -$21.88 million in the year ended Dec 31, 2014 and -$26.11 million in the year ended Dec 31, 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 274.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -2.32 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Grifols 4.97 Bn 4.59 Bn 3.33 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2016 6.90 Mn
Dec 31, 2015 6.41 Mn
Dec 31, 2014 -21.88 Mn
Dec 31, 2013 -26.11 Mn
API Access

Grifols Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=GRFS&period=max&api_key=YOUR_API_KEY